Schneider Electric To Present at Pharmaceutical Manufacturing Execution Systems (MES) Conference

WHO:  Rick Gallisa, Director of Sales Operations at Schneider Electric, and Richard Parapar, former Sr. Principal Engineer and Technical Lead at Genentech and now principal at batchinformatics, will present how to best implement electronic Batch Record Review (eBRR) to gain Return on Investment. Gallisa and Parapar will challenge attendees to think differently about their batch record review process. eBRR presents an opportunity to automate a traditionally paper-based manual process to improve visibility into the manufacturing process, minimize resource allocation for quality review and accelerate lot release.

In addition, Gallisa will moderate a panel discussion on “Lessons Learned in Selecting and Partnering with the Right MES Vendor.” Gallisa’s nearly two decades of experience working in manufacturing and at MES solution providers will be leveraged to help participants navigate this often challenging process. 

WHAT:  The Pharmaceutical Manufacturing Execution Systems (MES) Conference will explore topics of pivotal importance to provide a tremendous opportunity for collaboration between peers on what solutions best address today’s critical challenges within the pharmaceutical manufacturing.

WHERE:  Charlotte, NC; learn more about this event here

WHEN:  October 3-4, 2016.

Download this announcement in PDF format.

About Schneider Electric 

Schneider Electric is the global specialist in energy management and automation. With revenues of ~€25 billion in FY2016, our 144,000 employees serve customers in over 100 countries, helping them to manage their energy and process in ways that are safe, reliable, efficient and sustainable. From the simplest of switches to complex operational systems, our technology, software and services improve the way our customers manage and automate their operations. Our connected technologies reshape industries, transform cities and enrich lives. At Schneider Electric, we call this Life Is On.

« Return to News Room